Skip to main content

Advertisement

SpringerLink
Log in

The relationship between HIV infection and atopic dermatitis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Patients with HIV infection exhibit a wide range of skin pathology, including bacterial, fungal, and viral infections, skin tumors, inflammatory and eczematous eruptions, and drug rashes. HIV-infected adults commonly develop a condition that strongly resembles atopic dermatitis and is sometimes called “atopic-like dermatitis”; moreover, atopic dermatitis and other atopic disorders have been described as common manifestations of pediatric HIV infection. Conditions such as sinusitis, asthma, and hyper-IgE syndrome, and laboratory abnormalities, eg, elevated IgE levels, eosinophilia, and possible Th1-Th2 imbalances, suggest a predilection for atopic disorders in these patients. It is of interest to examine the immune perturbations intrinsic to HIV infection, and their possible role in triggering atopic dermatitis, and to consider whether other abnormalities, such as xerosis, bacterial or viral superantigens, or epidermal barrier disruption with altered presentation of cutaneous aeroallergens, might play a significant role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ball LM, Harper JI: Atopic eczema in HIV-seropositive haemophiliacs. Lancet 1987, 2:627–628.

    Article  PubMed  CAS  Google Scholar 

  2. Ellaurie M, Rubinstein A, Rosenstreich DL: IgE levels in pediatric HIV-1 infection. Ann Allergy Asthma Immunol 1995, 75:332–336.

    PubMed  CAS  Google Scholar 

  3. Morar N, Dlova N, Gupta AK, et al.: Erythroderma: a comparison between HIV positive and negative patients. Int J Dermatol 1999, 38:895–900.

    Article  PubMed  CAS  Google Scholar 

  4. Ishii N, Takahashi K, Sugita Y, Nakajima H: Atopic dermatitis apparently caused by type 2 CD8+ T cells in an AIDS patient. Clin Exp Dermatol 1998, 23:121–122.

    Article  PubMed  CAS  Google Scholar 

  5. Hoashi M, Imayama S, Hori Y, Kashiwagi S: An AIDS patient with atopic dermatitis-like eruption responsive to systemic anti-fungal treatment. J Dermatol 1992, 19:972–975.

    PubMed  CAS  Google Scholar 

  6. Supanaranond W, Desakorn V, Sitakalin C, et al.: Cutaneous manifestations in HIV positive patients. Southeast Asian J Trop Med Public Health 2001, 32:171–176.

    PubMed  CAS  Google Scholar 

  7. Saurat JH: Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol Suppl 1985, 114:125–128.

    CAS  Google Scholar 

  8. Vigano A, Principi N, Crupi L, et al.: Elevation of IgE in HIVinfected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995, 95:627–632.

    Article  PubMed  CAS  Google Scholar 

  9. Koutsonikolis A, Nelson RP Jr, Fernandez-Caldas E, et al.: Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol 1996, 97:692–697.

    Article  PubMed  CAS  Google Scholar 

  10. Skiest DJ, Keiser P: Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 1997, 102:449–453.

    Article  PubMed  CAS  Google Scholar 

  11. Paganelli R, Fanales-Belasio E, Scala E, et al.: Serum eosinophil cationic protein (ECP) in human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1991, 88:416–418.

    Article  PubMed  CAS  Google Scholar 

  12. Lin RY, Lazarus TS: Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann Allergy Asthma Immunol 1995, 74:510–515.

    PubMed  CAS  Google Scholar 

  13. Bacot BK, Paul ME, Navarro M, et al.: Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol 1997, 100:707–711.

    Article  PubMed  CAS  Google Scholar 

  14. Tubiolo VC, Vazzo LA, Beall GN: Food allergy in human immunodeficiency virus (HIV) infection. Ann Allergy Asthma Immunol 1997, 78:209–212.

    PubMed  CAS  Google Scholar 

  15. Sample S, Chernoff DN, Lenahan GA, et al.: Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals. J Allergy Clin Immunol 1990, 86:876–880.

    Article  PubMed  CAS  Google Scholar 

  16. Sanchez-Borges M, Orozco A, Di Biagio E, et al.: Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993, 92:494–495.

    Article  PubMed  CAS  Google Scholar 

  17. Paganelli R, Scala E, Mezzaroma I, et al.: Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995, 95:995–1003.

    Article  PubMed  CAS  Google Scholar 

  18. Cone LA, Woodard DR, Byrd RG, et al.: A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992, 165:638–643.

    PubMed  CAS  Google Scholar 

  19. Nakazawa M, Sugi N, Kawaguchi H, et al.: Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997, 99:673–682.

    Article  PubMed  CAS  Google Scholar 

  20. Thepen T, Langeveld-Wildschut EG, et al.: Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996, 97:828–837.

    Article  PubMed  CAS  Google Scholar 

  21. Reinhold U, Kukel S, Goeden B, et al.: Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991, 86:444–448.

    Article  PubMed  CAS  Google Scholar 

  22. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al.: Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992, 90:184–193.

    Article  PubMed  Google Scholar 

  23. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-gamma in atopic eczema. Lancet 1994, 343:25–26.

    Article  PubMed  CAS  Google Scholar 

  24. Grewe M, Walther S, Gyufko K, et al.: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995, 105:407–410.

    Article  PubMed  CAS  Google Scholar 

  25. Higashi N, Bang K, Gesser B, et al.: Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol 2001, 81:3–7. Unstimulated cultures of T-cell lines from atopic dermatitis patients expressed a type-1 profile. Stimulation with anti-CD3 and anti-CD28 monoclonal antibodies caused rapid initial upregulation of type-2 cytokines followed by a type 1 profile. Strong upregulation of interleukin-10 was observed after 24 hours of stimulation.

    PubMed  CAS  Google Scholar 

  26. Horsmanheimo L, Harvima IT, Jarvikallio A, et al.: Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994, 131:348–353.

    Article  PubMed  CAS  Google Scholar 

  27. Snijders A, Van der Pouw Kraan TC, Engel M, et al.: Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998, 111:472–476.

    Article  PubMed  CAS  Google Scholar 

  28. de Jong EC, Vieira PL, Kalinski P, et al.: Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002, 168:1704–1709.

    PubMed  Google Scholar 

  29. Kondo H, Ichikawa Y, Imokawa G: Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998, 28:769–779. Tape-stripping experiments in mice demonstrate allergens applied to barrier-disrupted skin induce a type-2 cytokine reaction pattern.

    Article  PubMed  CAS  Google Scholar 

  30. Nissen D, Nolte H, Permin H, et al.: Evaluation of IgE-sensitization to fungi in HIV-positive patients with eczematous skin reactions. Ann Allergy Asthma Immunol 1999, 83:153–159. In HIV-positive patients with eczema, there was an IgE response against fungal antigens in the majority of patients. The IgE response was most often directed against a 46-kD main protein in the Candida albicans extract.

    Article  PubMed  CAS  Google Scholar 

  31. Marshall JD, Chehimi J, Gri G, et al.: The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999, 94:1003–1011.

    PubMed  CAS  Google Scholar 

  32. Mikovits JA, Young HA, Vertino P, et al.: Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol 1998, 18:5166–5177.

    PubMed  CAS  Google Scholar 

  33. Clerici M, Hakim FT, Venzon DJ, et al.: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993, 91:759–765.

    Article  PubMed  CAS  Google Scholar 

  34. Maggi E, Mazzetti M, Ravina A, et al.: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994, 265:244–248.

    Article  PubMed  CAS  Google Scholar 

  35. Graziosi C, Pantaleo G, Gantt KR, et al.: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIVinfected individuals. Science 1994, 265:248–252.

    Article  PubMed  CAS  Google Scholar 

  36. Maggi E, Giudizi MG, Biagiotti R, et al.: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994, 180:489–495.

    Article  PubMed  CAS  Google Scholar 

  37. Agarwal SK, Marshall GD Jr.: In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. Hum Immunol 1998, 59:99–105.

    Article  PubMed  CAS  Google Scholar 

  38. Chehimi J, Ma X, Chouaib S, et al.: Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1996, 12:1141–9.

    Article  PubMed  CAS  Google Scholar 

  39. Empson M, Bishop GA, Nightingale B, Garsia R: Atopy, anergic status, and cytokine expression in HIV-infected subjects. J Allergy Clin Immunol 1999, 103:833–842. Analysis of mRNA expression in PBMCs from HIV patients by noncompetitive dot-blot PCR showed a decline in type-1 cytokine expression not accompanied by a decline in type-2 cytokines. Low constitutive in vivo expression of IL-12 mRNA significantly correlated with anergy.

    Article  PubMed  CAS  Google Scholar 

  40. Cavagni G, Caffarelli C, Facchetti F, et al.: Cutaneous CD30+ cells in children with atopic dermatitis. Int Arch Allergy Immunol 2000, 121:224–228. CD30 expression occurs in very high proportions of infiltrating cells in childhood eczema. Total serum IgE, sCD30, sIL-2R, sCD23, and eosinophils were significantly elevated compared with controls.

    Article  PubMed  CAS  Google Scholar 

  41. Frezzolini A, Paradisi M, Ruffelli M, et al.: Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997, 52:106–109.

    Article  PubMed  CAS  Google Scholar 

  42. Bengtsson A, Holm L, Back O, et al.: Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997, 109:533–537.

    Article  PubMed  CAS  Google Scholar 

  43. Yamamoto J, Adachi Y, Onoue Y, et al.: CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000, 55:1011–1018.

    Article  PubMed  CAS  Google Scholar 

  44. Smith KJ, Barrett TL, Neafie R, et al.: Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease? Br J Dermatol 1998, 138:774–779.

    Article  PubMed  CAS  Google Scholar 

  45. Hamann D, Hilkens CM, Grogan JL, et al.: CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996, 156:1387–1391.

    PubMed  CAS  Google Scholar 

  46. Nakamura T, Lee RK, Nam SY, et al.: Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol 1997, 158:2090–2098.

    PubMed  CAS  Google Scholar 

  47. Del Prete G, Maggi E, Pizzolo G, Romagnani S: CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995, 16:76–80.

    Article  PubMed  Google Scholar 

  48. Patella V, Florio G, Petraroli A, Marone G: HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol 2000, 164:589–595. HIV gp120, which acts as a viral superantigen, interacts with the VH3 region of IgE to induce the release of IL-4 and IL-13 from human FceRI+ cells.

    PubMed  CAS  Google Scholar 

  49. de Paulis A, De Palma R, Di Gioia L, et al.: Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol 2000, 165:7171–7179. Tat protein, an HIV-1-encoded beta-chemokine homologue, influences the directional migration of human FceRI(+) cells and the expression of surface receptor CCR3 on these cells.

    PubMed  Google Scholar 

  50. Li Y, Li L, Wadley R, et al.: Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 2001, 97:3484–3490. Mast cells and basophils in the blood of HIV-infected patients are susceptible to infection by M-tropic HIV-1 strains.

    Article  PubMed  CAS  Google Scholar 

  51. Skov L, Olsen JV, Giorno R, et al.: Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000, 105:820–826.

    Article  PubMed  CAS  Google Scholar 

  52. Zollner TM, Wichelhaus TA, Hartung A, et al.: Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000, 30:994–1000. Colonization with superantigen-producing strains of Staphylococcus aureus correlates with increased severity of atopic dermatitis as a result of a superantigen effect rather than a direct allergenic effect of the superantigen.

    Article  PubMed  CAS  Google Scholar 

  53. Davison S, Allen M, Vaughan R, Barker J: Staphylococcal toxininduced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000, 121:181–186.

    Article  PubMed  CAS  Google Scholar 

  54. Brinchmann JE, Gaudernack G, Thorsby E, Vartdal F: Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells. J Virol 1992, 66:5924–5928.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1048, 10029, New York, NY, USA

    Donald Rudikoff MD

Authors
  1. Donald Rudikoff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rudikoff, D. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep 2, 275–281 (2002). https://doi.org/10.1007/s11882-002-0050-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-002-0050-x

Keywords

Search

Navigation